A comprehensive view of AbbVie Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
AbbVie Inc. Enhances Industry Presence with Strategic Symposium on Hematologic Oncology at SFH Congress
Published:
March 28, 2024
by Industry Intelligence Inc.
|
AbbVie Inc.'s Mobile Podcast 'Cancers du sang, nos vies' Hits the Road, Partnering with Patient Associations to Illuminate Blood Cancer Journeys
Published:
March 27, 2024
by Industry Intelligence Inc.
|
AbbVie Inc. Bolsters Immunology Presence with Landos Biopharma Acquisition and Advances Production Efficiency via Inaugural OpEx Academy
Published:
March 26, 2024
by Industry Intelligence Inc.
|
AbbVie to acquire Landos Biopharma for an estimated US$212.5M; deal includes NX-13, a potentially ground-breaking oral treatment for conditions such as ulcerative colitis and Crohn's disease
Published:
March 25, 2024
by AbbVie Inc.
|
AbbVie Inc. Secures FDA Approval for Ovarian Cancer Treatment, Expanding Presence in Solid Tumor Oncology and Committing to Global Oncologic Innovation
Published:
March 23, 2024
by Industry Intelligence Inc.
|
Ask us about our Health Care Sector market view